Marco Monrouzeau is the general manager and CFO of the Puerto Rican affiliate of Mexican drug maker Neolpharma, which has manufacturing operations at its site in Caguas. Monrouzeau highlights how Neolpharma has started its operations on the island in 2013 and since then has developed significant R&D capabilities to be able to roll out its product to the US market.
Neolpharma's main business is in Mexico, but the Puerto Rican affiliate has opened the door to the US market for the company
Allied Logistics, a leading Puerto Rican provider of transportation services, storage and distribution, is working in pursuit of one vision: to be the dominant supply chain management provider for mid…
Salvador Montes, director of Essentra Packaging in Puerto Rico, explains how the company has positioned itself as the preferred supplier of secondary packaging to the life sciences industry on the…
Droguería Betances (DB), Puerto Rico’s local leader in distribution of healthcare pharmaceutical prescription drug, products and services, has been teaming up for over ten years with Luis Garratón Inc. (LGI),…
Puerto Rico had to rebuild itself – in many cases quite literally – after the devastation wrought by Hurricane Maria in 2017. However, despite the havoc that Maria brought to…
When life sciences companies decide to transfer the production of new drug to Puerto Rico, extend an existing production line, or simply sustain existing operations, they can count on the…
Going into a pharmacy has never been more convenient in the United States and its territories. People living near urban centres need not travel far to find a 24 hour-supermarket-style…
See our Cookie Privacy Policy Here